Yan-Cheng Wang

Shandong Provincial Hospital

Papers

1

Total Citations

8

H-Index

1

About

Dr. Yan-Cheng Wang is a pioneering thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for early-stage non-small cell lung cancer (NSCLC). His major contributions center on comparing the efficacy and recovery outcomes of robot-assisted thoracoscopic surgery (RATS) versus uniportal video-assisted thoracoscopic surgery (UVATS), with a particular emphasis on functional recovery indices. In his most cited work, a 2023 propensity score-matched analysis, Dr. Wang demonstrated that three-port robot-assisted lobectomy offers superior postoperative functional recovery compared to uniportal video-assisted lobectomy, providing critical insights for optimizing surgical approaches in NSCLC treatment. This study, garnering 8 citations, has already influenced clinical decision-making in thoracic oncology. Dr. Wang’s research is notable for its rigorous prospective design and patient-centered outcomes, bridging the gap between technological innovation and practical recovery metrics. His work continues to shape the evolution of lung cancer surgery, offering patients less invasive options with faster return to normal function.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Comparison Results of Three-Port Robot-Assisted and Uniportal Video-Assisted Lobectomy for Functional Recovery Index in the Treatment of Early Stage Non-small Cell Lung Cancer: A Propensity Score-Matched Analysis
8 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Shandong Provincial Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago